Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-005300

Director sold 53,000 shares at $7.59 ($402,270)

From the SEC's structured data for this filing

Trades in this filing

HERSHBERG ROBERT · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-12 Sale : show line 1 in the form −53,000 $7.59 $402,270 69,690 D
Open-market sales · 53,000 sh · avg $7.59 · $402,270
Loading xslF345X05/form4.xml…